KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Operating Leases (2021 - 2025)

Historic Operating Leases for Castle Biosciences (CSTL) over the last 5 years, with Q3 2025 value amounting to $25.3 million.

  • Castle Biosciences' Operating Leases rose 7222.79% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.3 million, marking a year-over-year increase of 7222.79%. This contributed to the annual value of $14.3 million for FY2024, which is 121.36% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Operating Leases is $25.3 million, which was up 7222.79% from $25.4 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Operating Leases registered a high of $25.4 million during Q2 2025, and its lowest value of $6.5 million during Q2 2022.
  • Over the past 5 years, Castle Biosciences' median Operating Leases value was $13.5 million (recorded in 2023), while the average stood at $13.5 million.
  • Per our database at Business Quant, Castle Biosciences' Operating Leases soared by 9177.47% in 2023 and then soared by 121.36% in 2024.
  • Quarter analysis of 5 years shows Castle Biosciences' Operating Leases stood at $6.9 million in 2021, then soared by 67.14% to $11.5 million in 2022, then grew by 22.89% to $14.2 million in 2023, then increased by 1.21% to $14.3 million in 2024, then skyrocketed by 76.38% to $25.3 million in 2025.
  • Its Operating Leases stands at $25.3 million for Q3 2025, versus $25.4 million for Q2 2025 and $14.0 million for Q1 2025.